A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)
Clinical trial NCT05724199 · COMPLETED
Trial details
- NCT number
- NCT05724199
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2024-09-15
- Enrollment
- 746
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.